BioSpace News Archive

Adlai Nortye Ltd., a clinical-stage biopharmaceutical company focused on the development of innovative cancer therapies, is pleased to welcome new senior level talent to its dynamic global leadership team.

Kairos Pharma, Ltd., a privately held clinical stage biotechnology company focused on drug resistance and immunotherapy for cancer, announced that its activated T cell therapy, KROS 201, has received FDA approval to proceed with a Phase 1 clinical trial in patients with recurrent glioblastoma, a type of brain cancer.

Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced that it will host a conference call and webcast at 4:30 p.m. ET on Monday, March 28, 2022, to discuss its financial and operating results for the fourth quarter and full year of 2021.

Transcat, Inc. announced that Lee D. Rudow, President and Chief Executive Officer, and Mark A. Doheny, Chief Financial Officer, will present and be available for investor meetings at the Sidoti Small Cap Virtual Investor Conference on Wednesday, March 23 and Thursday, March 24, 2022.

Growing prevalence of cancer, infectious diseases, and blood-related disorders and rising demand for point-of-care diagnostics are among the major factors expected to drive market revenue growth.

Increasing use of virtual reality in surgical training and patient treatment, rapid technological advancements in VR headsets, and rising application of VR in medical education are some key factors expected to drive market growth.

The global behavioral health market size is expected to be worth around US$ 242 billion by 2027 and poised to grow at a CAGR of 5.02% over the forecast period 2021 to 2027.

According to Precedence Research, the global medical fiber optics market size is expected to reach US$ 1,536.2 million by 2030 from valued at US$ 929.63 million in 2021, with a CAGR of 5.7% from 2022 to 2030.

Element Biosciences Launches the AVITI ™ System to Democratize Access to Genomics.

Jaguar Health, Inc. announced that the recording of the company’s March 14, 2022, investor webcast regarding company updates and reported consolidated financial results for the year ended December 31, 2021 can be accessed by clicking here.